IgA nephropathy at two score and one.

[1]  C. Ponticelli,et al.  Kidney transplantation in patients with IgA mesangial glomerulonephritis. , 2001, Kidney international.

[2]  D. Centonze,et al.  Urine protein profile of IgA nephropathy patients may predict the response to ACE‐inhibitor therapy , 2008, Proteomics.

[3]  F. Eitner,et al.  Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. , 2008, Journal of nephrology.

[4]  I. Roberts,et al.  Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.

[5]  J. Barratt,et al.  B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. , 2008, Kidney international.

[6]  Kunihiko Kobayashi,et al.  Degalactosylated and/or Denatured IgA, but Not Native IgA in Any Form, Bind to Mannose-Binding Lectin1 , 2006, The Journal of Immunology.

[7]  Yusuke Suzuki,et al.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.

[8]  B. Julian,et al.  Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy , 2008, Kidney and Blood Pressure Research.

[9]  M. Hristov,et al.  No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  G. Signoriello,et al.  Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Sandrine Florquin,et al.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.

[12]  L. Peruzzi,et al.  Serum IgA and macromolecular IgA reacting with mesangial matrix components. , 1993, Contributions to nephrology.

[13]  Claudio Pozzi,et al.  Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. , 2004, Journal of the American Society of Nephrology : JASN.

[14]  Fernand,et al.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.

[15]  L. Peruzzi,et al.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. , 2007, Journal of the American Society of Nephrology : JASN.

[16]  Y. Tomino.  IgA nephropathy: lessons from an animal model, the ddY mouse. , 2008, Journal of nephrology.

[17]  J. Barratt,et al.  Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. , 1999, Journal of the American Society of Nephrology : JASN.

[18]  K. Kitamura,et al.  Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[19]  R. Lifton,et al.  Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[20]  Y. Hiki,et al.  Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1998, Journal of the American Society of Nephrology : JASN.

[21]  I. Narita,et al.  The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. , 2003, Kidney international.

[22]  M. Kerr,et al.  The structure and function of human IgA. , 1990, The Biochemical journal.

[23]  T. Taguchi,et al.  Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[24]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.

[25]  F. Lai,et al.  Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. , 2008, American journal of physiology. Renal physiology.

[26]  R. Monteiro.  Pathogenic role of IgA receptors in IgA nephropathy. , 2007, Contributions to nephrology.

[27]  E. Morales,et al.  Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. , 2003, Journal of the American Society of Nephrology : JASN.

[28]  G. Alarcón,et al.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.

[29]  J. D. de Fijter,et al.  GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. , 2008, Kidney international.

[30]  M. Rastaldi,et al.  Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  K. Kimura,et al.  Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  Peggo K. W. Lam,et al.  Recurrent IgA nephropathy in renal transplant allografts. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  Y. Yamaguchi,et al.  Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. , 2003, Kidney international.

[34]  L. Peruzzi,et al.  Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation , 2007, Clinical transplantation.

[35]  Hong Zhang,et al.  Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. , 2007, Kidney international.